Phase 2 Lymphoma Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You have been diagnosed with Mycosis Fungoides (MF), a type of skin lymphoma, confirmed by a tissue sample (biopsy), and it affects your skin.
• You have at least one skin lesion that can be seen and measured during a physical exam.
• If you were previously diagnosed with MF and have developed a new skin lesion, that new lesion may be eligible without needing another biopsy.
• Your skin lesion(s) are no taller than 1 cm (about the height of a small fingernail) when measured from the skin surface — and if you have multiple lesions meeting this requirement, each one may be enrolled separately.
• You have any stage of MF (from early to advanced) where radiation therapy is being considered to treat a specific lesion.
• You are currently receiving or planning to start a systemic (whole-body) treatment for more advanced disease.
• If you are a woman who could become pregnant, you have had a negative pregnancy blood test within the past 2 weeks, or you have signed a declaration confirming you are not pregnant.
• You are using or planning to use certain skin-based treatments (such as topical chemotherapy, retinoids, or imiquimod) on other lesions not being enrolled in the trial — as long as the lesion being enrolled has not had those treatments applied for at least 24 hours before joining the study.

Who may not be able to join:

• You are currently pregnant.
• You have been diagnosed with active lupus or scleroderma (certain autoimmune conditions).
• The skin lesion being considered for the trial is taller than 1 cm when measured from the skin surface.
• The lesion being considered for enrollment has had topical chemotherapy, retinoids, or imiquimod applied to it within the last 24 hours (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.